SMLR NASDAQ
Semler Scientific, Inc.
1W: -6.8%
1M: -22.6%
3M: -50.7%
1Y: -75.8%
3Y: -51.6%
5Y: -83.3%
$20.33
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$56M
-17.4% ▼
5Y CAGR: +11.4%
Gross Profit
$52M
-15.8% ▼
5Y CAGR: +12.1%
Operating Income
$21M
-5.9% ▼
5Y CAGR: +14.3%
Net Income
$41M
+98.7% ▲
5Y CAGR: +22.1%
EPS (Diluted)
$5.13
+95.1% ▲
5Y CAGR: +22.2%
EBITDA
$22M
-8.8% ▼
5Y CAGR: +13.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $39M | $53M | $57M | $68M | $56M |
| YoY Growth | +17.8% | +37.4% | +6.9% | +20.3% | -17.4% |
| Cost of Revenue | $3M | $6M | $4M | $7M | $5M |
| Gross Profit | $35M | $47M | $52M | $61M | $52M |
| Gross Margin | 91.3% | 88.5% | 92.5% | 89.8% | 91.5% |
| R&D Expenses | $3M | $4M | $5M | $6M | $5M |
| SG&A Expenses | $16M | $24M | $30M | $32M | $26M |
| Operating Expenses | $19M | $27M | $35M | $39M | $31M |
| Operating Income | $16M | $19M | $17M | $22M | $21M |
| Operating Margin | 41.3% | 36.7% | 30.3% | 32.6% | 37.2% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $16M | $19M | $18M | $24M | $48M |
| Tax Expense | $2M | $2M | $3M | $4M | $7M |
| Net Income | $14M | $17M | $14M | $21M | $41M |
| Net Margin | 36.3% | 32.5% | 25.3% | 30.2% | 72.7% |
| EPS (Diluted) | $1.74 | $2.12 | $1.79 | $2.63 | $5.13 |
| EBITDA | $17M | $20M | $18M | $24M | $22M |
| Shares Outstanding | 8M | 8M | 8M | 8M | 8M |